LQDA

Liquidia Corporation · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website liquidia.com
Employees(FY) 63
ISIN US53635D2027

Performance

+5.45%

+2.28%

+18.09%

-12.74%

-6.65%

YTD

+51.35%

Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Advanced Technical Analysis

Technical Analysis of LQDA 2024-12-02

The stock exhibits a bullish sentiment with a Moving Average Score of 76, indicating strong upward momentum, while the Oscillators Score of 40 suggests a neutral stance, and the overall Technical Score of 58 reflects a cautious outlook. This combination implies that while the stock shows potential for growth, there may be some underlying volatil...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of LQDA

Stock Rank

Recent News & Updates

2024-11-26 09:55
Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High?(Zacks)
2024-11-19 10:04
3 US Growth Stocks With At Least 10% Insider Ownership(Simply Wall St.)
2024-11-15 05:59
Liquidia Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
2024-11-14 02:09
Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...(GuruFocus.com)
2024-11-13 07:40
Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates(Zacks)
2024-11-13 06:30
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update(GlobeNewswire)
2024-11-12 17:30
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-11-12 08:00
Liquidia to Present at the Stifel 2024 Healthcare Conference(GlobeNewswire)
2024-11-11 19:00
Liquidia to Present at the Stifel 2024 Healthcare Conference(Globenewswire)
2024-11-08 07:04
Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result(GuruFocus.com)
2024-11-07 06:27
Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?(Zacks)
2024-11-07 05:49
Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years(Simply Wall St.)
2024-11-06 08:00
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024(GlobeNewswire)
2024-11-05 19:00
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024(Globenewswire)
2024-11-04 08:00
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024(GlobeNewswire)
2024-11-03 19:00
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024(Globenewswire)
2024-11-01 10:00
Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know(Zacks)
2024-10-29 10:01
Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release(Zacks)
2024-10-17 15:31
3 US Growth Stocks With High Insider Ownership And Earnings Growth Up To 61%(Simply Wall St.)
2024-10-16 08:36
Scotiabank Initiates Liquidia at Sector Outperform With $30 Price Target(MT Newswires)
2024-10-09 17:12
Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...(GuruFocus.com)
2024-10-08 09:34
Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?(Zacks)
2024-10-07 12:40
Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute(MT Newswires)
2024-10-07 10:00
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent(GlobeNewswire)
2024-10-06 22:00
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent(Globenewswire)
2024-10-02 06:57
Liquidia Expands Exclusive Licensing Agreement with Pharmosa Biopharm(MT Newswires)
2024-10-02 06:00
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)(GlobeNewswire)
2024-10-01 18:00
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)(Globenewswire)
2024-09-30 09:00
Bragar Eagel & Squire, P.C. Is Investigating Liquidia, Napco, and Franklin and Encourages Investors to Contact the Firm(Globenewswire)
2024-09-30 08:00
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting(GlobeNewswire)

Page 1 of 9

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.